Latest Regulatory News

Page 396 of 632
Macro Metals Limited is poised to resume trading on the ASX from July 18, 2025, following a key Supreme Court decision. The lifting of its trading suspension marks a significant regulatory milestone for the mining company.
Maxwell Dee
Maxwell Dee
17 July 2025
Macro Metals Limited has obtained crucial Supreme Court orders to address a regulatory oversight involving cleansing notices, paving the way for the lifting of its trading suspension.
Maxwell Dee
Maxwell Dee
17 July 2025
Vintage Energy has addressed an ASX compliance issue related to the timing of its May 2025 securities issuance, confirming reliance on its placement capacities to maintain regulatory adherence.
Maxwell Dee
Maxwell Dee
17 July 2025
Raptis Group Limited has confirmed the resignation of director James Raptis effective September 30, 2025, amid a sharp rise in its share price and trading volume. The company denies any other undisclosed information behind the recent market activity.
Victor Sage
Victor Sage
17 July 2025
MIXI Australia has lodged a bidder’s statement for an all-cash $1.20 per share takeover offer for PointsBet Holdings Limited, with the PointsBet Board unanimously recommending acceptance in the absence of a superior proposal.
Sophie Babbage
Sophie Babbage
17 July 2025
Silk Logistics Holdings has scheduled its shareholder meeting for August 1 to vote on the proposed $2.14 per share acquisition by DP World Australia, with an independent expert reaffirming the deal’s fairness.
Victor Sage
Victor Sage
17 July 2025
Scalare Partners Holdings Limited has had its trading suspension lifted following its announcement of a capital raising to fund the acquisition of Tank Stream Labs.
Claire Turing
Claire Turing
17 July 2025
Lumos Diagnostics has locked in a A$5 million secured loan facility to support working capital as it advances toward FDA CLIA waiver for its FebriDx® test, complementing a landmark US distribution deal.
Ada Torres
Ada Torres
17 July 2025
Australian Rare Earths (ASX, AR3) has responded to an ASX price query, denying any undisclosed price-sensitive information and attributing recent trading activity to sector interest and recent company announcements.
Maxwell Dee
Maxwell Dee
17 July 2025
Clarity Pharmaceuticals has successfully completed recruitment for its pivotal Co-PSMA Phase II trial, testing its novel Cu-SAR-bisPSMA diagnostic against the current standard in detecting prostate cancer recurrence. This milestone advances their mission to improve early detection and treatment outcomes for men with low PSA levels.
Ada Torres
Ada Torres
17 July 2025
Nova Minerals has closed a US$11.1 million underwritten offering on NASDAQ, positioning itself to advance exploration and feasibility studies at its Estelle Gold and Critical Minerals Project in Alaska.
Maxwell Dee
Maxwell Dee
17 July 2025
Locksley Resources has confirmed multiple new mineralised trends at its Mojave Critical Minerals Project in California, setting the stage for an expanded drilling campaign in Q3 2025. The company’s detailed structural mapping and 3D geological modelling have refined exploration targets for antimony and rare earth elements, aligning with growing US strategic interests in domestic critical minerals.
Maxwell Dee
Maxwell Dee
17 July 2025